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RESEARCH ARTICLE Open Access
A cross sectional study of anemia and iron
deficiency as risk factors for arsenic-
induced skin lesions in Bangladeshi women
Molly L. Kile1*, Joycelyn M. Faraj2, Alayne G. Ronnenberg2, Quazi Quamruzzaman3, Mahmudar Rahman3,
Golam Mostofa3, Sakila Afroz3 and David C. Christiani4
Abstract
Background: In the Ganges Delta, chronic arsenic poisoning is a health concern affecting millions of people who
rely on groundwater as their potable water source. The prevalence of anemia is also high in this region, particularly
among women. Moreover, arsenic is known to affect heme synthesis and erythrocytes and the risk of arsenic-induced
skin lesions appears to differ by sex.
Methods: We conducted a case-control study in 147 arsenic-exposed Bangladeshi women to assess the association
between anemia and arsenic-induced skin lesions.
Results: We observed that the odds of arsenic-related skin lesions were approximately three times higher among
women who were anemic (hemoglobin < 120 g/L) compared to women with normal hemoglobin levels [Odds Ratio
(OR) = 3.32, 95 % Confidence Intervals (CI): 1.29, 8.52] after adjusting for arsenic levels in drinking water and other
covariates. Furthermore, 75 % of the women with anemia had adequate iron stores (serum ferritin ≥12 μg/L), suggesting
that the majority of anemia detected in this population was unrelated to iron depletion.
Conclusions: Considering the magnitude of arsenic exposure and prevalence of anemia in Bangladeshi women,
additional research is warranted that identifies the causes of anemia so that effective interventions can be implemented
while arsenic remediation efforts continue.
Keywords: Arsenic, Skin lesions, Anemia, Ferritin, Inflammation, C-reactive protein
Background
National groundwater surveys suggest that millions of
people living in Bangladesh are at risk of ingesting
arsenic-contaminated water as the result of a public
health initiative that switched the population’s drinking
water from surface to groundwater by installing shallow
tubewells [27]. The concentration of arsenic in these
shallow tubewells ranges from non-detectable to up-
wards of 2,000 μg/L. It is estimated that approximately
59 % of the tubwells tested exceed the Bangladesh drink-
ing water standard of 50 μg/L [27]. Inorganic arsenic is a
known human carcinogen, and chronic exposure in-
creases the risk of cancers of the skin, bladder, lung, and
kidney [10, 39, 41]. Chronic exposure to arsenic is also
associated with non-cancer outcomes including bron-
chitis, cardiovascular disease, adverse reproductive out-
comes, and type 2 diabetes [12, 14, 15, 24, 33, 40]. The
first dermal signs of arsenic toxicity manifest as melan-
osis and/or leukomelanosis, keratosis, and hyperkeratosis
of the palms and soles [15]. Prospective epidemiologic
studies have demonstrated that the risk of arsenic-
related skin lesions increases in a dose-dependent
manner and that the presence of skin lesions are highly
associated with risk of cancer later in life [4, 23].
Considerable evidence supports the observation that
arsenic can influence many aspects of the heme system.
Previous research has shown that arsenic decreases
heme metabolism and can bind to hemoglobin, resulting
in lower hemoglobin concentrations [22, 25]. Arsenic
has been shown to alter erythrocyte morphology and
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induce erythrocyte death [7, 17, 28, 48]. Arsenic also
depresses bone marrow, which can lead to anemia
(hemoglobin < 120 g/L in non-pregnant adults), leukopenia,
and thrombocytopenia [38]. There have also been two med-
ical case reports describing patients with megaloblastic
anemia in conjunction with chronic arsenic exposure where
one person had normal folate status [46] whereas the other
case had low folate status [44]. Additionally, previous
research by our group found that men with higher
hemoglobin levels when measured continuously had lower
odds of skin lesions after adjusting for confounders [9].
The prevalence of anemia in rural Bangladeshi women
is high. Population-based surveys have reported that up
to 43 % of rural Bangladeshi adolescent girls and 49 % of
pregnant women are anemic [1]. Anemia has significant
health implications for both women and their offspring
because women who are anemic during pregnancy are at
increased risk of maternal mortality and preterm birth
[35]. Additionally, other studies have reported that
women who were anemic prior to conception were more
likely to have infants with lower birth weight and more
fetal growth restriction [34, 35]. Iron deficiency is fre-
quently cited as the most common cause of anemia in
underprivileged populations [42]. However, one study,
which examined both anemia and iron status among
rural Bangladeshi women, reported that iron deficiency
was absent in a large percentage of Bangladeshi women
who exhibited anemia and that parity and thalassemia
were the most common predictors of anemia [31]. This
study, which also looked at arsenic exposure, did not re-
port any relationship between drinking water arsenic
(>50 μg/L) and anemia. However, another large popula-
tion study conducted in rural Bangladesh reported that
hemoglobin levels <100 g/L were significantly associated
with high urinary arsenic concentrations, lower body mass
index, low intake of iron, and contraceptive use [21].
Consequently, we used existing data collected in a case
control study designed to examine susceptibility factors for
arsenic-related skin lesions to further examine the relation-
ship between anemia and skin lesions among Bangladeshi
women. Since infection and inflammation can produce an
acute-phase response that increases hepatic ferritin synthe-
sis irrespective of iron status [8], we measured both serum
ferritin and high sensitive C-reactive protein (hs-CRP), a
commonly used biomarker of inflammation, to better
characterize anemia and iron status in this sub-set of
women. Our primary goal in this study was to evaluate the
following related hypotheses: 1) women with anemia de-
fined as hemoglobin levels <120 g/L had an increased risk
of arsenic-related skin lesions, 2) women with poor iron
status defined as a serum ferritin level ≤12 μg/L had an in-
creased risk of arsenic-related skin lesions; and 3) women
with inflammation defined as hs-CRP levels ≥10 mg/L had
an increased risk of arsenic-related skin lesions.
Methods
Study population
A case-control study was performed in the Pabna district
of Bangladesh from 2001 to 2003. Participant selection
and study procedures have been described previously in
detail [9, 30]. Briefly, 900 individuals with one or more
type of arsenic-related skin lesion (diffuse/spotted mel-
anosis, diffuse/spotted keratosis, hyperkeratosis, or leu-
komelanosis) and 900 controls were recruited. Controls
did not have any visible sign of arsenic-related skin le-
sions and were matched one-to-one with cases on loca-
tion of residence, age (within 3 years), and gender. All
participants were ≥16 years of age and were a resident in
one of the 23 villages served by Dhaka Community Hos-
pital Trust primary care clinics. A single physician who
was trained by Dhaka Community Hospital was respon-
sible for ascertaining status of skin lesions and was
blinded to arsenic exposure status in the participant’s
drinking water. However, given that severe skin lesions
frequently manifest on patient’s hands, it is likely that
the field staff was aware of chronic arsenic exposure sta-
tus in some cases. The physician also collected a toenail
sample and a venous blood sample. A trained staff mem-
ber administered questionnaires that collected behav-
ioral and demographic information, including age, sex,
marital status, tobacco and betel nut habits, education,
drinking water history, dietary habits, etc. A water sam-
ple was collected from the participant’s home.
For this analysis, we selected all women who were age
18 to 33 years and who had sufficient quantities of ar-
chived serum available for additional biomarker analysis.
Our rationale for restricting to this age range was to
capture women of reproductive age. The minimum age
of 18 years was due to the initial eligibility requirement
in the original case control study whereas the maximum
age of 33 years is a somewhat arbitrary cutoff that
allowed us to include all women in this age range rather
than randomly sample across a wider age range. This
strategy resulted in 75 cases and 72 unmatched controls.
Ethics statement
All study procedures were approved by the Human
Subjects Committee of the Harvard School of Public
Health and Dhaka Community Hospital. Additionally,
the current analysis was approved by the Human Subject
Committee at the University of Massachusetts Amherst.
All participants provided informed consent prior to par-
ticipating in any study activities.
Anemia and iron status assessment
At the time of enrollment, a whole blood sample was
collected. Serum was isolated by centrifugation within
several hours of collection and frozen at –20 °C immedi-
ately after processing. Serum samples were shipped on
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dry ice to Harvard School of Public Health, where sam-
ples underwent one freeze-thaw cycle in order to create
aliquots prior to storage at -80 °C. Frozen serum samples
were transported on dry ice to the Department of Nutri-
tion, University of Massachusetts Amherst, where they
were stored at -80 °C until biomarker assessment.
Hemoglobin was measured using Sahli’s method at the
time the participant was recruited into the study [5]. Fol-
lowing the WHO definition, women who had a hemoglobin
level <120 g/L were defined as having anemia [42].
Serum ferritin concentrations were measured using a
commercially available enzyme immunoassay kit follow-
ing manufacturer’s instructions (Ramco Laboratories
Inc., Stafford, TX); absorbance was read at a wavelength
of 490 nm with a correction filter set at 520 nm (MRX
Microplate Reader, Revelation). Women who had serum
ferritin levels ≤12 μg/L were defined as having iron defi-
ciency; women who also had a hemoglobin level <120 g/L
were classified as having iron-deficiency anemia.
Inflammation assessment
High-sensitivity C-reactive protein (hs-CRP) was mea-
sured in serum using a commercially available immuno-
assay test kit following manufacturer’s instructions
(Biocheck, Inc., Foster City, CA); absorbance was read at
a wavelength of 450 nm (MRX microplate reader). This
assay has been validated by numerous researchers [19, 45].
We chose to classify women with hs-CRP levels ≥10 mg/L
as having inflammation. This cut-off level was chosen be-
cause it is related to levels in patients with acute inflam-
mation, infections and any other serious inflammatory
condition [29]. Because ferritin levels can be speciously el-
evated due to infection or inflammation, rather than iron
sufficiency, we also classified women as having iron defi-
ciency in the presence of inflammation if serum ferritin
levels were <50 μg/L and hs-CRP was ≥10 mg/L.
Arsenic exposure assessment
Arsenic was measured in participants’ drinking water
and their toenails at the time the participant enrolled in
the study. Arsenic levels in toenails are used as bio-
markers of personal exposure and provide an integrated
measure of exposures that occurred over the previous
year and are highly correlated with arsenic exposure
from drinking water [26].
Drinking water samples were collected from the tubewell
identified by the participant as her primary source of drink-
ing water. The samples were preserved with nitric acid and
stored at room temperature. Arsenic concentrations in the
water were measured using inductively-coupled plasma
mass spectrometry (ICP-MS) by Environmental Laboratory
Services, North Syracuse, NY, USA. The method limit of
detection was 1 μg As/L. Samples below the limit of
detection were set to 0.5 μg/L. The average percentage of
recovery of standard reference material (PlasmaCAL multi-
element QC standard #1 solution, SCP Science, Canada)
was 104.6 %.
Toenail clippings underwent a cleaning process to
remove external contamination before being digested in
ultra-pure nitric acid following the method described by
Chen et al. [11]. Arsenic concentrations were quantified
using ICP-MS (ICP-MS Model 6100 DRC, Perkin-Elmer,
Norwalk, CT) at the Harvard School of Public Health.
The measured concentrations were batch-corrected for
any detectable arsenic in method blanks, and this cor-
rected value was subsequently used in all statistical ana-
lyses. The average percentage of recovery of standard
reference materials NIST 1643 (Trace Metals in Water)
and CRM hair was 92.6 % and 94.1 %, respectively.
Statistical analysis
Descriptive statistics and correlation coefficients were
calculated for all variables. Chi-square tests for categor-
ical data, t-tests for comparison of means, and one-sided
Wilcoxon rank sum test were used to 1) compare the
characteristics between the subset of women included in
this analysis and all other women recruited into the case
control study and 2) compare characteristics between
women who had arsenic-related skin lesions and women
without arsenic-related skin lesions. The distribution of
serum ferritin, hs-CRP, water arsenic, and toenail arsenic
were highly skewed and subsequently transformed using
natural logarithms to achieve normal distributions.
These transformed variables were then used in the linear
and logistic regression models.
We used separate linear and logistic regression models
to evaluate the association between arsenic-related skin le-
sions (dependent variable) and i) anemia (anemia [yes/no]
and hemoglobin [continuous]), ii) iron status (iron defi-
ciency [yes/no], serum ferritin (continuous), iron defi-
ciency with inflammation [yes/no]), iii) inflammation
(inflammation [yes/no],and iv) hs-CRP (continuous). Due
to the small number of women who were classified with
iron-deficiency anemia, the association between this con-
dition and skin lesions was not evaluated. Crude and ad-
justed odds ratios (OR) and 95 % confidence intervals (CI)
were computed for the parameters of interest. The effect-
estimates for the continuous variables were scaled by
interquartile range (IQR), which reflects the change in the
odds of skin lesions per increase in 1 IQR of hemoglobin,
serum ferritin, or hs-CRP. Covariates were only included
in the models if they were significantly associated with
arsenic exposure, skin lesions, or considered to be con-
founders. Consequently, final models were adjusted for
body mass index (BMI, <18.5 kg/m2, 18.5–24.9 kg/m2,
and >25 kg/m2), age, and education. To facilitate the
translation of model results, age was centered at its mean,
and education was centered at primary educational level.
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All statistical analyses were completed using SAS
version 9.3 (Cary, North Carolina, USA).
Results
This analysis highlighted a subset of 147 women who
participated in a case-control study of skin lesions con-
ducted from 2001–2003. To determine if we had intro-
duced bias into our study, we compared this subset to all
women recruited into the case control study (n = 543).
We observed that the subset of women were youn-
ger (p < 0.001), less likely to ever have been married
(p < 0.001), less likely to chew betel nuts (p < 0.001),
more likely to use a tubewell that had lower arsenic
levels (p = 0.02), and had completed more years of
formal schooling (p < 0.001), compared to the larger
group of women who were enrolled in the case con-
trol study (Table 1). Consequently, the subset of
women included in this analysis may not reflect the
general population of women of reproductive age in
this region. Instead, this subset reflects women of re-
productive age with more moderate arsenic exposure
levels and a higher educational status.
The median concentration of arsenic in the tube-
wells used by the subset of women in this study was
17.2 μg As/L (Table 1). Participants, on average,
reported using their current tube well for 7.5 years
(SD: 6.3 years; Range = 1–35 years). Toenail arsenic
reflects cumulative exposure over the past year and
the concentration of arsenic in toenails are highly
correlated with arsenic concentrations in drinking
Table 1 Selected characteristics compared between the subset of women who were eligible for this analysis and all other women
recruited into the case control study
Characteristic All women (n = 543) Subset (n = 147) p value
Variables n Mean ± SD n Mean ± SD
Age (years) 542 34.9 ± 11.3 147 25.5 ± 5.0 <0.001
Median ± IQR Median ± IQR
Water As (μg/L) 526 32.9 ± 269.4 146 17.2 ± 120.4 0.02
Toenail As (μg/g) 540 2.70 ± 6.97 145 2.12 ± 3.65 0.10
% %
Skin Lesions 0.80
No 272 50.18 72 48.98
Yes 270 49.82 75 51.02
Body Mass Index (kg/m2) 0.70
<18.5 158 29.10 44 29.93
18.5–24.9 332 61.14 92 62.59
≥25 53 9.76 11 7.48
Marital Status <0.001
Not married 72 13.33 37 25.17
Ever married 468 86.67 110 74.83
Education <0.001
No formal education 318 58.56 53 36.1
Primary 74 13.63 17 11.56
Secondary and above 150 27.62 77 52.38
Chews betel nut <0.001
No 385 71.2 131 89.7
Yes 156 28.8 15 10.3
Water Arsenic 0.16
≤10 ug/L 196 36.10 65 44.22
10–50 ug/L 130 23.94 34 23.13
>50 ug/L 217 39.96 48 32.65
Hemoglobin (g/L) 0.99
Normal (Hb ≥120 g/L) 443 81.58 120 81.63
Anemia (Hb <120 g/L) 100 18.42 27 18.37
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water (σspearman = 0.42, p value <0.0001). Anemia and
poor iron status defined as a serum ferritin level ≤12 μg/L
were fairly common with 18.4 % (n = 27) of the women
considered to be anemic (hemoglobin <120 g/L) and
18.4 % (n = 27) of the women considered to be iron
depleted (serum ferritin ≤12 μg/L) (Table 2). Yet, only
25.9 % (n = 7) of women who were anemic were also clas-
sified as iron depleted, suggesting that iron deficiency
anemia was not the predominant type of anemia in this
population. We also observed that 9.5 % (n = 14) of the
Table 2 Comparison of selected characteristics between women with skin lesions and women without skin lesions
Characteristic Controls (n = 72) Cases (n = 75) p value
Variables n Mean ± SD n Mean ± SD
Age (years) 72 25.7 ± 5.3 75 25.4 ± 4.8 0.99 (0.93, 1.05)
Hemoglobin (g/L) 71 128.9 ± 10.1 75 123.9 ± 14.5 0.72 (0.55, 0.95)
Median ± IQR Median ± IQR
Ferritin (μg/L) 72 27.35 ± 35.5 75 29.4 ± 39.7 1.14 (0.80, 1.61)
hs-CRP (mg/L) 63 0.71 ± 2.44 71 1.11 ± 2.57 1.20 (0.92, 1.55)
Water As (μg/L) 72 14.5 ± 48.4 74 37.7 ± 268.0 1.04 (0.92, 1.19)
Toenail As (μg/g) 71 1.58 ± 1.65 74 3.38 ± 8.55 1.88 (1.32, 2.68)
% %
Body Mass Index (kg/m2)
<18.5 15 20.8 29 38.7 3.38 (0.85, 13.41)
18.5–24.9 50 69.4 42 56.0 2.30 (1.09, 4.85)
≥25 7 9.7 4 5.3 Ref.
Marital Status
Single/Unmarried 17 23.6 20 26.7 Ref.
Ever Married 55 76.4 55 73.3 0.85 (0.40, 1.79)
Education
No formal education 23 31.9 30 40.0 1.74 (0.86, 3.52)
Primary 5 6.94 12 16.0 0.54 (0.17, 1.76)
Secondary and above 44 61.11 33 44.0 Ref.
Chews betel nut
No 64 88.9 67 90.5 Ref.
Yes 8 11.1 7 9.5 1.05 (0.37, 2.96)
Water Arsenic
≤10 ug/L 30 41.7 35 46.7 Ref.
10–50 ug/L 24 33.3 10 13.3 2.80 (1.16, 6.78)
>50 ug/L 18 25.0 30 40.0 0.70 (0.33, 1.50)_
Inflammation
No (hs-CRP <10 mg/L) 65 90.3 68 90.7 Ref.
Yes (hs-CRP ≥10 mg/L) 7 9.7 7 9.3 1.05 (0.35, 3.15)
Iron depletion
No (ferritin >12 μg/L) 58 80.6 62 82.7 Ref.
Yes (ferritin ≤12 μg/L) 14 19.4 13 17.3 1.15 (0.50, 2.66)
Iron depletion w/inflammation
No 55 76.4 59 78.7 Ref.
Yes (ferritin ≤50 μg/L) 17 23.6 16 21.3 1.15 (0.50, 2.66)
Anemia
No (hemoglobin ≥120 g/L) 64 88.9 56 74.7 Ref.
Yes (hemoglobin <120 g/L) 8 11.1 19 25.3 2.71 (1.10, 6.68)
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women were classified as having systemic inflammation
(hs-CRP ≥ 10 mg/L), suggesting a possible acute response
to infection. Because inflammation can increase serum fer-
ritin levels, which was also observed in this study by a sig-
nificant positive correlation between hs-CRP levels and
serum ferritin (p value = 0.001), we extended the definition
of iron depletion to include serum ferritin level to <50 μg/L
in the presence of inflammation. This extension identified
six additional women with iron depletion, which increased
the estimated proportion of women with iron depletion to
22.5 % (n = 33).
Women with skin lesions were more likely to use a
tubewell with arsenic concentrations above the
Bangladesh drinking water standard of 50 μg/L com-
pared to women without skin lesions (p value = 0.01),
have higher toenail arsenic concentrations (p < 0.001),
and have lower body mass indexes (p = 0.05) (Table 2).
Women with skin lesions were also more likely to have
lower hemoglobin levels (123.9 g/L versus 128.9 g/L,
p = 0.02) and more likely to be anemic (25.3 % versus
11.1 %, p = 0.03). Additionally, women with skin le-
sions appeared to have elevated hs-CRP (1.11 mg/L
versus 0.71 mg/L, p = 0.06).. Other characteristics, in-
cluding age, serum ferritin, education, chewing betel
nut, and marital status, did not differ between cases
and controls (Table 2).
Separate logistic regression models examined the asso-
ciations between skin lesions and anemia, iron status,
and inflammation (Table 3). After adjusting for arsenic
exposure, age, educational status and BMI, the odds of
skin lesions were approximately 3 times higher in
women who were anemic compared to women without
anemia. The odds ratios between anemia and skin
lesions were consistent whether arsenic exposure was
Table 3 Odds ratios (OR) and confidence intervals (95 % CI) of skin lesions for women exposed to arsenic (As) with anemia,
inflammation, iron depletion, and iron depletion in the presence of inflammation
Reference group Model 1* Model 2†
OR 95 % CI OR 95 % CI
Drinking water As
Anemia
Hemoglobin < 120 g/L 2.87 (1.16, 7.11) 3.32 (1.29, 8.52)
Hemoglobin ≥ 120 g/L Ref. - Ref. -
Inflammation
hs-CRP ≥10 mg/L 1.10 (0.36, 3.36) 1.11 (0.35, 3.52)
hs-CRP < 10 mg/L Ref. - Ref. -
Iron depletion
Ferritin≤ 12 μg/L 1.20 (0.51, 2.84) 1.09 (0.44, 2.71)
Ferritin > 12 μg/L Ref. - Ref. -
Iron depletion w/inflammation
Ferritin < 50 μg/L and hs-CRP≥ 10 mg/L 1.19 (0.54, 2.62) 1.03 (0.44, 2.39)
Ferritin≥ 50 μg/L and hs-CRP < 10 mg/L Ref. - Ref. -
Toenail As
Anemia
Hemoglobin < 120 g/L 2.86 (1.08, 7.62) 3.16 (1.17, 8.56)
Hemoglobin ≥ 120 g/L Ref. - Ref. -
Inflammation
hs-CRP ≥10 mg/L 1.09 (0.33, 3.57) 1.03 (0.30, 3.49)
hs-CRP < 10 mg/L Ref. - Ref. -
Iron depletion
Ferritin≤ 12 μg/L 0.73 (0.30, 1.78) 0.74 (0.29, 1.88)
Ferritin > 12 μg/L Ref. - Ref. -
Iron depletion w/inflammation
Ferritin < 50 μg/L and hs-CRP ≥10 mg/L 0.77 (0.36, 1.77) 0.72 (0.30, 1.75)
Ferritin≥ 50 μg/L and hs-CRP <10 mg/L Ref. - Ref. -
*Model 1 only adjusts for arsenic exposure
†Model 2 adjusts for arsenic exposure, age, educational status, and body mass index
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measured in drinking water or toenails. This suggested
that the odds of skin lesions were reduced by approxi-
mately 40 % per IQR in hemoglobin levels after adjust-
ing for confounders (aORwater As: 0.60, 95 % CI: 0.39,
0.92; aORtoenail As: 0.58, 95 % CI: 0.37, 0.90). No signifi-
cant differences in the odds of skin lesions were ob-
served for women with inflammation compared to
women without inflammation or for women with iron
depletion compared to women with sufficient iron in ad-
justed models.
We further evaluated the dose-response relationship
between skin lesions and tertiles of hemoglobin, hs-CRP,
and serum ferritin using separate logistic regression
models that adjusted for arsenic exposure (either in
drinking water or toenails), age, educational status, and
BMI (Table 4). This approach also suggested that women
with higher levels of hemoglobin had a reduced risk of
skin lesions compared to women with the lowest levels
of hemoglobin in models that adjusted for arsenic in
drinking water or toenails but the trend was not signifi-
cant (drinking water As, p = 0.18; toenail As, p = 0.20).
This suggested that the clinical cut-off level for
hemoglobin-related anemia reasonably characterized the
risk between this factor and skin lesions. We also ob-
served a positive trend between women with the higher
levels of hs-CRP and increased odds of skin lesions
(drinking water As, p = 0.05; toenail As, p = 0.08) com-
pared to women with the lowest levels of hs-CRP (aOR
water As = 2.32, 95 % CI: 1.00, 5.37; aORtoenail As = 2.03,
95 % CI: 0.85, 4.87). This suggested an association
between inflammation and skin lesions. No apparent
trend was observed between the odds of skin lesions and
serum ferritin tertiles.
Discussion
The results from this population-based case control
study show that Bangladeshi women of reproductive age
with anemia had a 3-fold increased odds of skin lesions
compared to women who were not anemic, after adjust-
ing for arsenic exposure and other covariates. Further-
more, only 25.9 % of the women with anemia were iron
deficient, which suggests that the majority of anemia in
this population was not related to iron status. Another
study conducted in rural Bangladeshi women also re-
ports that the majority of anemia observed was not due
to iron deficiency but rather to parity and thalassemia
[31], two risk factors that were not captured in our
study. However, the women included in this analysis
were younger than the average rural Bangladeshi woman
of reproductive age and may not have had as many chil-
dren as observed by Merrill et al.
Considering the public health significance of anemia
on maternal and child health, as well as the magnitude
of arsenic-related illness in this region, further research
is needed to identify the causes of anemia in this popula-
tion to develop appropriate interventions. For instance,
inadequate intakes of folate or vitamin B12 may be con-
tributing to the anemia observed in this population.
These micronutrients are also required to metabolize in-
organic arsenic [20]. Several studies have shown that
deficiencies in these nutrients increase the risk of
arsenic-related health effects in both humans and ani-
mals [16, 32, 43]. Additionally, the prevalence of hyper-
homocysteinemia is reported to be high in this area [20],
thus supporting the notion that B-vitamin status and fol-
ate status in particular may be compromised in this
population. If this were the case, it would result in meg-
aloblastic anemia rather than the microcytic anemia asso-
ciated with iron-deficiency [2]. Histological examination
of the blood would be able to discern between these two
types of anemia and would provide important treatment
information since megaloblastic anemia results from folate
and vitamin B12 deficiency, whereas microcytic anemia
results from iron deficiency. Interestingly, megaloblastic
anemia has been observed in patients with low folate sta-
tus and adequate folate status who were suffering from
chronic arsenic poisoning [44, 46]. Thus, further data de-
scribing the relationship between chronic arsenic expos-
ure, specific types of anemia, and nutritional status could
help gain better insights into the pathology of arsenic tox-
icity and potential treatments.
Table 4 Comparisons of the odds ratios (OR) and confidence
intervals (95 % CI) for skin lesions in women by tertiles of
hemoglobin, hs-CRP, and serum ferritin
Outcome Drinking water as* Toenail as†
Adjusted OR 95 % CI Adjusted OR 95 % CI
Hemoglobin (g/L)
High (>130) Ref - Ref. -
Middle (120–130) 1.32 0.55, 3.20 1.32‡ 0.54, 3.26
Low (<120) 2.21 0.96, 5.13 2.18‡ 0.90, 5.27
P for trend 0.16 0.20
hs-CRP (mg/L)
High (>1.90) 2.32 (1.00, 5.37) 2.03 0.85, 4.87
Middle (0.57–.90) 2.47 (1.08, 5.65) 2.58 1.06, 6.10
Low (<0.57) Ref - Ref -
P for trend 0.05 0.08
Serum ferritin (μg/L)
High (>41.3) 1.35 (0.57, 3.19) 0.99 0.40, 2.46
Middle (20.6–41.3) 1.37 (0.59, 3.20) 1.07 0.44, 2.61
Low (<20.6) Ref - Ref -
P for trend 0.72 0.98
*Adjusted for arsenic exposure in drinking water, age, educational status, and BMI
†Adjusted for arsenic exposure in toenails, age, educational status, and BMI
‡Adjusted for arsenic exposure in toenails, age, and BMI
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It is also possible that arsenic exerts a direct toxic ef-
fect on erythrocytes that is contributing to the observed
anemia. Several studies have shown that arsenic alters
heme metabolism and contributes to lower hemoglobin
concentrations [7, 17, 22, 28, 38, 48]. While our study
did not observe any consistently significant association
between anemia or hemoglobin levels and arsenic expo-
sures (see Additional file 1: Table S1), another large
population-based study conducted in an arsenic-
endemic area of Bangladesh reported that high levels
of urinary arsenic were associated with low hemoglobin
levels (<100 g/L) in both men and women [21]. The
lack of consistent association between anemia and ar-
senic in our sample could be a function of its smaller
population size.
We also suggest a positive association between hs-CRP
and skin lesions with the strongest association observed
among the third of the participants with the highest
levels of this inflammatory biomarker. It is plausible that
chronic arsenic exposure produces systemic inflamma-
tion, which may be an underlying mechanism in the
pathogenesis of skin lesions. Several in vivo studies have
shown than arsenic can induce hs-CRP production [18],
increase vascular inflammation by inhibiting endothelial
nitric oxide synthase [13, 36, 37], and induce erythrocyte
death by increasing cytosolic Ca(2+) [28], which in turn
can have pro-inflammatory effects [6]. Thus, there may
be a cycle through which arsenic stimulates biochemical
pathways that generate oxidative stress, which negatively
impacts hematopoiesis as well as the underlying mech-
anism of skin diseases. However, since our case-control
study was cross-sectional, it is not possible to determine
the temporality of the relationship between arsenic,
hematopoeisis, inflammation, and skin lesions. Also, due
to the small sample size we could not look at interac-
tions between these parameters.
The characteristics for the women included in this
group were somewhat different than the larger female
population recruited into the skin-lesion study, and thus
our results might not be generalizable to women of all
ages who reside in arsenic-endemic regions. For in-
stance, the prevalence of chewing betel nut was lower in
this subset of women than the wider population which is
relevant because betel nut chewing is a risk factor for
folate deficiency in pregnant women [23]. Also, the
prevalence of anemia in our population was 18.4 %,
which was lower than what has been observed in other
female, non-pregnant populations in Bangladesh [1].
This lower percentage could be due the selected subpop-
ulation of women included in this analysis or the use of
the Sahli’s method to measure hemoglobin in the field
which is a colorimetric method that was used because of
its simplicity and ability to deliver results immediately to
participants. This method can also be subject to error
because it relies on a visual comparison to determine
hemoglobin concentrations. However, a study which
compared the Sahli’s method to autoanalyzer methods
reports that the Sahli’s method was in good agreement
with the autoanalyzer with a sensitivity of 98.2 % and
specificity of 66.2 % [3]. Also, the technicians that per-
formed the Sahli’s method were blinded to the partici-
pant’s drinking water arsenic levels, which would
minimize bias. However, since severe arsenic poisoning
manifests frequently manifests itself as palmar skin le-
sions, it is possible that field staff were aware of arsenic
status in some cases which could introduce systematic
misclassification of hemoglobin levels for patients with
palmar lesions. On a similar note, we classified as not
anemic 27 subjects whose hemoglobin concentration
was exactly 120 g/L. If we included these individuals in
the anemic group, the estimated prevalence of anemia
would have increased to 36 %.
Another limitation that must always be recognized is
potential misclassification of arsenic exposure, which
would introduce additional variability into the model.
However, we minimize this possibility by using personal
measurements of current exposure (drinking water ar-
senic) and historical measurements of cumulative expos-
ure (toenails). Another limitation is that we did not
collect information about genetic risk factors for anemia,
such as Thallasemia, or additional blood parameters
such as mean cell volume (MCV) or serum levels of fol-
ate and vitamin B12, which would have allowed us to dis-
tinguish between different causes of anemia. Finally, it
would have been ideal to include assessment of soluble
transferrin receptor concentration since this biomarker
reflects iron deficiency and is not affected by infection
or inflammation. However, we had limited biospecimens
and needed to prioritize assays. Thus, we chose to meas-
ure hs-CRP to assess inflammation even though serum
hs-CRP level spikes faster than ferritin and has a shorter
half-life [47]. As a result, we may not have been able to
identify all women who were actually iron deficient des-
pite “normal” ferritin levels {49]. Histological examin-
ation of the blood sample was not performed which
would have identified the presence of microcytic and
megaloblastic anemia nor were folate or vitamin B12
levels measured in these participants due to limited
serum availability. Future studies should consider includ-
ing this information in order to further characterize
anemia in this population and identify appropriate treat-
ment strategies.
Conclusion
In conclusion, this case-control study identified anemia
and inflammation as significant risk factors for skin le-
sions after controlling for arsenic exposure and other
confounders. Further studies are thereby justified to
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determine the causes or types of anemia in this popula-
tion, to explain the causal relationship between anemia
and skin lesions, and to better define the role that ar-
senic plays in both these conditions so that appropriate
public health interventions can be implemented.
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